DRAM vs. BBP

Last updated Jun 9, 2026

DRAM (Roundhill Memory ETF) and BBP (Virtus LifeSci Biotech Products ETF) are both exchange-traded funds - DRAM is a Technology Equities fund actively managed by Roundhill, while BBP is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Products Index. DRAM is actively managed, while BBP is passively managed. At a 0.38 correlation, their price movements are largely independent. DRAM charges 0.65%/yr vs 0.79%/yr for BBP.

Performance

DRAM vs. BBP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Roundhill Memory ETF (DRAM) and Virtus LifeSci Biotech Products ETF (BBP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

DRAM

• 1D: 8.48%
• 1M: 14.62%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

BBP

• 1D: -0.72%
• 1M: -4.70%
• YTD: 5.23%
• 6M: 7.53%
• 1Y: 39.09%
• 3Y*: 15.67%
• 5Y*: 9.36%
• 10Y*: 11.99%

*Multi-year figures are annualized to reflect compound growth (CAGR)

DRAM vs. BBP - Yearly Performance Comparison

	2026 (YTD)
DRAM Roundhill Memory ETF	124.15%
BBP Virtus LifeSci Biotech Products ETF	0.44%

Correlation

The correlation between DRAM and BBP is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Apr 2, 2026	0.38

DRAM vs. BBP - Sectors Allocation Comparison

Sectors	DRAM	BBP
Technology	100.0%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Healthcare	-	100.0%
Industrials	-	-
Real Estate	-	-
Utilities	-	-

Return for Risk

DRAM vs. BBP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBP

BBP Risk / Return Rank: 64
BBP Sharpe Ratio Rank: 54
BBP Sortino Ratio Rank: 56
BBP Omega Ratio Rank: 49
BBP Calmar Ratio Rank: 85
BBP Martin Ratio Rank: 76

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DRAM vs. BBP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Roundhill Memory ETF (DRAM) and Virtus LifeSci Biotech Products ETF (BBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	DRAM	BBP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.65	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.36	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.44	—
Sharpe Ratio (All Time) Calculated using the full available price history	91.43	0.39	+91.04

Drawdowns

DRAM vs. BBP - Drawdown Comparison

The maximum DRAM drawdown since its inception was -19.97%, smaller than the maximum BBP drawdown of -44.32%. Use the drawdown chart below to compare losses from any high point for DRAM and BBP.

Drawdown Indicators

	DRAM	BBP	Difference
Max Drawdown Largest peak-to-trough decline	-19.97%	-44.32%	+24.35%
Max Drawdown (1Y) Largest decline over 1 year	—	-9.28%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-26.09%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-38.28%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-44.32%	—
Current Drawdown Current decline from peak	-13.18%	-6.96%	-6.22%
Average Drawdown Average peak-to-trough decline	-2.40%	-12.02%	+9.62%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	3.02%	—

Volatility

Volatility by Period

	DRAM	BBP	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	6.81%	—
Volatility (6M) Calculated over the trailing 6-month period	—	18.58%	—
Volatility (1Y) Calculated over the trailing 1-year period	85.85%	23.85%	+62.00%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	85.85%	26.34%	+59.51%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	85.85%	27.41%	+58.44%

DRAM vs. BBP - Expense Ratio Comparison

DRAM has a 0.65% expense ratio, which is lower than BBP's 0.79% expense ratio.

Dividends

DRAM vs. BBP - Dividend Comparison

Neither DRAM nor BBP has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBP Virtus LifeSci Biotech Products ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.18%	0.00%	1.29%
DRAM Roundhill Memory ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both DRAM and BBP in my portfolio?

DRAM and BBP have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, DRAM or BBP?

On fees, DRAM is cheaper at 0.65% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, DRAM or BBP?

DRAM is cheaper with a 0.65% expense ratio, compared with 0.79% for BBP.

Which ETF pays a higher dividend yield, DRAM or BBP?

DRAM and BBP have nearly identical dividend yields, around 0.00%.

What is the main difference between DRAM and BBP?

DRAM is categorized as Technology Equities, while BBP is Health & Biotech Equities. They also come from different issuers: Roundhill and Virtus Investment Partners. Their fees differ too: 0.65% for DRAM and 0.79% for BBP.